GRIFOLS | GRF - Equity Capital And Reserves


GRIFOLS reported EUR7.98B in Equity Capital and Reserves for its fiscal quarter ending in June of 2026.





Equity Capital And Reserves Change Date
Alcon AG USD 21.6B 538M Jun/2026
Almirall EUR 1.53B 43.26M Jun/2026
Amadeus IT EUR 4.57B 229.6M Jun/2026
Amarin USD 443.62M 5.8M Jun/2026
argenx SE USD 8.42B 1.09B Jun/2026
AstraZeneca USD 50.3B 2.96B Jun/2026
Bayer EUR 29.71B 863M Jun/2026
Cie Automotive EUR 1.45B 46.93M Dec/2025
Demant DKK 11.24B 1.4B Jun/2026
Ence Energia y Celulosa EUR 545.2M 48.76M Mar/2026
Essilor EUR 39.22B 329M Jun/2026
Ferrovial EUR 7.4B 269M Jun/2026
Fresenius EUR 19.7B 766M Jun/2026
Fresenius Medical Care EUR 13.53B 673.44M Jun/2026
Genmab DKK 5.96B 275M Jun/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Inditex 18.99B 193M Mar/2026
Lakefront Biotherapeutics EUR 3.26B 10.26M Jun/2026
Merck EUR 30.17B 430M Jun/2026
Novartis USD 41.95B 3.02B Jun/2026
Philips EUR 11.48B 84M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Smith & Nephew USD 5.18B 356M Jun/2026
UCB EUR 10.87B 1.18B Dec/2025
Viscofan EUR 911.32M 20.72M Jun/2026